X

Xiamen Amoytop Biotech Co Ltd
SSE:688278

Watchlist Manager
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Watchlist
Price: 74.6 CNY 0.53% Market Closed
Market Cap: ¥30.5B

Relative Value

The Relative Value of one Xiamen Amoytop Biotech Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 74.6 CNY, Xiamen Amoytop Biotech Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Xiamen Amoytop Biotech Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Xiamen Amoytop Biotech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Xiamen Amoytop Biotech Co Ltd
SSE:688278
30.3B CNY 9.1 32.3 27.7 27.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
374.7B USD 6.5 164.4 16 22.7
US
Amgen Inc
NASDAQ:AMGN
196.8B USD 5.5 28.1 19.9 19.9
US
Gilead Sciences Inc
NASDAQ:GILD
180.8B USD 6.2 22.3 15.2 15.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.6B USD 10.2 32.7 24 25.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.8B USD 5.7 18.1 15.4 17.5
AU
CSL Ltd
ASX:CSL
87.7B AUD 3.9 20.3 13.6 16.9
NL
argenx SE
XBRU:ARGX
44.4B EUR 14.5 34.2 58.4 60
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average P/S: 3 058 675.9
9.1
32%
0.3
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.5
5%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
6.2
4%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.2
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
8%
0.7
AU
CSL Ltd
ASX:CSL
3.9
5%
0.8
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average P/E: 44
32.3
35%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
164.4
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
28.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.3
191%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
9%
2
AU
CSL Ltd
ASX:CSL
20.3
11%
1.8
NL
argenx SE
XBRU:ARGX
34.2
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average EV/EBITDA: 23.8
27.7
32%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
19.9
11%
1.8
US
Gilead Sciences Inc
NASDAQ:GILD
15.2
7%
2.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
24%
0.6
AU
CSL Ltd
ASX:CSL
13.6
8%
1.7
NL
argenx SE
XBRU:ARGX
58.4
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average EV/EBIT: 25.6
27.7
31%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
19.9
20%
1
US
Gilead Sciences Inc
NASDAQ:GILD
15.2
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.1
16%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
23%
0.8
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
NL
argenx SE
XBRU:ARGX
60
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A